Target intelligence / Profile preview

FSHD region gene 2 pseudogene (FRG2P)

Target: FRG2P
Molecular classification: Pseudogene

Overview

The FSHD region gene 2 pseudogene (FRG2P, ENSG00000249435) is a human genomic locus classified as a pseudogene. It does not encode a functional protein and has no established biological function. It is not currently considered a drug target and is not directly involved in human disease, though it is located in the genomic region studied for its association with facioscapulohumeral muscular dystrophy (FSHD). Its presence in annotation reflects genomic structure rather than a role in disease or cellular physiology[1][3][7].

Other names: FRG2PAC022137.2

Mechanism of action

None (not a druggable target or functional protein)

Biological functions

None established (pseudogenes typically do not encode functional proteins or have known biological activity in cell physiology)

Disease associations

None directly established; however, related FSHD region genes are associated with facioscapulohumeral muscular dystrophy (FSHD), though not this pseudogene specifically. This gene itself is not implicated as causative in FSHD

Safety considerations

None (irrelevant due to lack of function; no therapeutic targeting)

Interacting drugs

None (no known drugs interact with this pseudogene)

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on FSHD region gene 2 pseudogene (FRG2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSHD region gene 2 pseudogene (FRG2P).

Explore the full profile